Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 14, 2018

Total Value: $187M (100.0% shares, 0.0% debt)

Holdings (30)

— BIOSPECIFICS TECHNOLOGIES 14.0%

Value $26.16M Shares 590,025 Est. Cost $45.13 Unrealized —

— CTI BIOPHARMA CORP 10.7%

Value $20.05M Shares 5,141,746 Est. Cost $3.59 Unrealized —

— AMARIN CORP PLC -ADR 9.3%

Value $17.34M Shares 5,761,581 Est. Cost $3.01 Unrealized —

VNDA VANDA PHARMACEUTICALS INC 8.9%

Value $16.59M Shares 984,584 Est. Cost $14.90 Unrealized +12.3%

— APOLLO ENDOSURGERY INC 8.7%

Value $16.15M Shares 2,577,996 Est. Cost $4.75 Unrealized —

— VIVEVE MEDICAL INC 7.5%

Value $14.09M Shares 3,849,711 Est. Cost $6.92 Unrealized —

CPIX CUMBERLAND PHARMACEUTICALS 4.7%

Value $8.838M Shares 1,323,041 Est. Cost $5.83 Unrealized +18.2%

— BIODELIVERY SCIENCES INTL 4.5%

Value $8.339M Shares 3,706,084 Est. Cost $2.06 Unrealized —

— CARDIOME PHARMA CORP 4.0%

Value $7.52M Shares 3,241,550 Est. Cost $2.49 Unrealized —

— NOVELION THERAPEUTICS INC 3.5%

Value $6.51M Shares 1,860,000 Est. Cost $8.14 Unrealized —

— ALIMERA SCIENCES INC 3.4%

Value $6.365M Shares 6,180,033 Est. Cost $1.20 Unrealized —

— DOVA PHARMACEUTICALS INC 2.7%

Value $4.99M Shares 184,000 Est. Cost $27.12 Unrealized —

— OPHTHOTECH CORP 2.3%

Value $4.365M Shares 1,593,119 Est. Cost $4.39 Unrealized —

VCYT VERACYTE INC 2.3%

Value $4.303M Shares 773,889 Est. Cost $7.51 Unrealized -17.6%

— CONFORMIS INC 2.2%

Value $4.028M Shares 2,777,711 Est. Cost $1.45 Unrealized —

— OXFORD IMMUNOTEC GLOBAL PLC 1.8%

Value $3.286M Shares 263,974 Est. Cost $12.45 Unrealized —

— CANCER GENETICS INC 1.6%

Value $2.925M Shares 1,772,741 Est. Cost $1.85 Unrealized —

— MEDICREA INTERNATIONAL 1.5%

Value $2.778M Shares 714,729 Est. Cost $3.60 Unrealized —

— STEADYMED LTD 1.3%

Value $2.344M Shares 721,308 Est. Cost $3.64 Unrealized —

— INVUITY INC 1.0%

Value $1.952M Shares 507,028 Est. Cost $3.85 Unrealized —

— GEMPHIRE THERAPEUTICS INC 0.8%

Value $1.581M Shares 242,812 Est. Cost $6.51 Unrealized —

— SIERRA ONCOLOGY INC 0.6%

Value $1.182M Shares 570,987 Est. Cost $2.07 Unrealized —

— INVITAE CORP 0.6%

Value $1.027M Shares 219,022 Est. Cost $4.69 Unrealized —

— ZOSANO PHARMA CORP 0.5%

Value $1.008M Shares 200,000 Est. Cost $5.04 Unrealized —

— FOAMIX PHARMACEUTICALS LTD 0.4%

Value $666K Shares 129,756 Est. Cost $5.13 Unrealized —

EOLS EVOLUS INC 0.3%

Value $535K Shares 59,229 Est. Cost $11.44 Unrealized 0.0%

— IMMUNE DESIGN CORP 0.3%

Value $532K Shares 161,226 Est. Cost $3.30 Unrealized —

— SCYNEXIS INC 0.3%

Value $509K Shares 380,083 Est. Cost $1.34 Unrealized —

— EYENOVIA INC 0.2%

Value $365K Shares 39,902 Est. Cost $9.15 Unrealized —

— AQUINOX PHARMACEUTICALS INC 0.2%

Value $287K Shares 20,374 Est. Cost $11.75 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	BIOSPECIFICS TECHNOLOGIES	590,025	$26.16M	14.0%	$45.13	—	COM	090931106
—	CTI BIOPHARMA CORP	5,141,746	$20.05M	10.7%	$3.59	—	COM NEW	12648L601
—	AMARIN CORP PLC -ADR	5,761,581	$17.34M	9.3%	$3.01	—	SPONS ADR NEW	023111206
VNDA	VANDA PHARMACEUTICALS INC	984,584	$16.59M	8.9%	$14.90	+12.3%	COM	921659108
—	APOLLO ENDOSURGERY INC	2,577,996	$16.15M	8.7%	$4.75	—	COM	03767D108
—	VIVEVE MEDICAL INC	3,849,711	$14.09M	7.5%	$6.92	—	COM NEW	92852W204
CPIX	CUMBERLAND PHARMACEUTICALS	1,323,041	$8.838M	4.7%	$5.83	+18.2%	COM	230770109
—	BIODELIVERY SCIENCES INTL	3,706,084	$8.339M	4.5%	$2.06	—	COM	09060J106
—	CARDIOME PHARMA CORP	3,241,550	$7.52M	4.0%	$2.49	—	COM NO PAR	14159U301
—	NOVELION THERAPEUTICS INC	1,860,000	$6.51M	3.5%	$8.14	—	COM NEW	67001K202
—	ALIMERA SCIENCES INC	6,180,033	$6.365M	3.4%	$1.20	—	COM	016259103
—	DOVA PHARMACEUTICALS INC	184,000	$4.99M	2.7%	$27.12	—	COM	25985T102
—	OPHTHOTECH CORP	1,593,119	$4.365M	2.3%	$4.39	—	COM	683745103
VCYT	VERACYTE INC	773,889	$4.303M	2.3%	$7.51	-17.6%	COM	92337F107
—	CONFORMIS INC	2,777,711	$4.028M	2.2%	$1.45	—	COM	20717E101
—	OXFORD IMMUNOTEC GLOBAL PLC	263,974	$3.286M	1.8%	$12.45	—	ORD SHS	G6855A103
—	CANCER GENETICS INC	1,772,741	$2.925M	1.6%	$1.85	—	COM	13739U104
—	MEDICREA INTERNATIONAL	714,729	$2.778M	1.5%	$3.60	—	COM	F6112U109
—	STEADYMED LTD	721,308	$2.344M	1.3%	$3.64	—	SHS	M84920103
—	INVUITY INC	507,028	$1.952M	1.0%	$3.85	—	COM NEW	46187J205
—	GEMPHIRE THERAPEUTICS INC	242,812	$1.581M	0.8%	$6.51	—	COM	36870A108
—	SIERRA ONCOLOGY INC	570,987	$1.182M	0.6%	$2.07	—	COM	82640U107
—	INVITAE CORP	219,022	$1.027M	0.6%	$4.69	—	COM	46185L103
—	ZOSANO PHARMA CORP	200,000	$1.008M	0.5%	$5.04	—	COM NEW	98979H202
—	FOAMIX PHARMACEUTICALS LTD	129,756	$666K	0.4%	$5.13	—	SHS	M46135105
EOLS	EVOLUS INC	59,229	$535K	0.3%	$11.44	0.0%	COM	30052C107
—	IMMUNE DESIGN CORP	161,226	$532K	0.3%	$3.30	—	COM	45252L103
—	SCYNEXIS INC	380,083	$509K	0.3%	$1.34	—	COM	811292101
—	EYENOVIA INC	39,902	$365K	0.2%	$9.15	—	COM	30234E104
—	AQUINOX PHARMACEUTICALS INC	20,374	$287K	0.2%	$11.75	—	COM	03842B101